Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.66 USD | +2.47% |
|
+4.40% | -37.83% |
Jun. 26 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
Jun. 26 | Sector Update: Health Care Stocks Lower in Afternoon Trading | MT |
Financials (USD)
Sales 2024 * | 59.5K | Sales 2025 * | 50K | Capitalization | 2.43M |
---|---|---|---|---|---|
Net income 2024 * | -12M | Net income 2025 * | -14M | EV / Sales 2024 * | 40.8 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 48.6 x |
P/E ratio 2024 * |
-0.34
x | P/E ratio 2025 * |
-0.38
x | Employees | 12 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 75.37% |
Latest transcript on Cyclacel Pharmaceuticals, Inc.
1 day | +2.47% | ||
1 week | +4.40% | ||
Current month | +2.47% | ||
1 month | -37.12% | ||
3 months | -21.70% | ||
6 months | -37.36% | ||
Current year | -37.83% |
![Extreme 1.5533](/images/extremecours_fleche.png)
![Extreme 1.45](/images/extremecours_fleche.png)
![Extreme 1.3](/images/extremecours_fleche.png)
![Extreme 1.3](/images/extremecours_fleche.png)
![Extreme 1.3](/images/extremecours_fleche.png)
![Extreme 1.3](/images/extremecours_fleche.png)
![Extreme 1.3](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Spiro Rombotis
CEO | Chief Executive Officer | 65 | 97-07-31 |
Paul McBarron
DFI | Director of Finance/CFO | 63 | 01-12-31 |
Brian Schwartz
CTO | Chief Tech/Sci/R&D Officer | 52 | 20-12-16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 83 | 06-02-28 | |
Brian Schwartz
CTO | Chief Tech/Sci/R&D Officer | 52 | 20-12-16 |
Spiro Rombotis
CEO | Chief Executive Officer | 65 | 97-07-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-07-02 | 1.66 | +2.47% | 14,238 |
24-07-01 | 1.62 | 0.00% | 65,492 |
24-06-28 | 1.62 | -4.71% | 74,079 |
24-06-27 | 1.7 | -10.55% | 141,021 |
24-06-26 | 1.9 | +19.53% | 942,841 |
Delayed Quote Nasdaq, July 02, 2024 at 04:00 pm EDT
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.83% | 2.43M | |
+16.44% | 122B | |
+18.94% | 113B | |
+18.08% | 26.22B | |
-25.37% | 19.01B | |
-19.70% | 15.71B | |
-20.20% | 15.22B | |
-47.37% | 14.72B | |
+59.91% | 14.58B | |
+4.35% | 13.84B |
- Stock Market
- Equities
- CYCC Stock